Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 9
Submit an article Journal homepage
167
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era

Sotirios G. Papageorgiou2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece; Correspondence[email protected]
,
Christos K. KontosDepartment of Biochemistry and Molecular Biology, University of Athens, Athens, Greece;
,
Periklis G. Foukas2nd Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University Hospital, Haidari, Greece
,
Eleni Panopoulou2nd Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University Hospital, Haidari, Greece
,
Diamantina Vasilatou2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece;
,
Stamatia-Maria RaptiDepartment of Biochemistry and Molecular Biology, University of Athens, Athens, Greece;
,
Konstantinos Gkontopoulos2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece;
,
Efthimia Bazani2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece;
,
Ioannis G. Panayiotides2nd Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University Hospital, Haidari, Greece
,
George Dimitriadis2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece;
,
Andreas ScorilasDepartment of Biochemistry and Molecular Biology, University of Athens, Athens, Greece;
&
Vasiliki Pappa2nd Department of Internal Medicine, Propaedeutic, Hematology Unit, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University General Hospital, Haidari, Greece;
show all
Pages 2199-2203 | Received 17 Sep 2015, Accepted 26 Nov 2015, Published online: 14 Jan 2016

References

  • Jaffe ES, Harris NL, Stein H, et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008;112:4384–4399.
  • A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329: 987–994.
  • Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2005;23:4117–4126.
  • Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7:379–391.
  • Tzifi F, Economopoulou C, Gourgiotis D, et al. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012;2012:524308
  • Horn H, Ziepert M, Becher C, et al. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood 2013;121:2253–2263.
  • Monti S, Chapuy B, Takeyama K, et al. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 2012;22:359–372.
  • Scorilas A, Kyriakopoulou L, Yousef GM, et al. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics 2001;72:217–221.
  • Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630–1636.
  • Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007;109:1857–1861.
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275–282.
  • Papageorgiou SG, Kontos CK, Pappa V, et al. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. Oncologist 2011;16:1280–1291.
  • Seki R, Ohshima K, Fujisaki T, et al. Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lym-phoma in the rituximab era. Cancer Sci. 2009;100:1842–1847.
  • Wilson KS, Sehn LH, Berry B, et al. CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma. Leuk Lymphoma 2007;48:1102–1109.
  • Salles G, de Jong D, Xie W, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood 2011;117:7070–7078.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.